Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor.

A new, more holistic approach to testing is needed to avoid mistakes that can cause harm, said Marcus Schabacker, CEO of the patient safety group ECRI.

Johnson & Johnson did not provide Auris Health with resources to achieve regulatory milestones after acquiring the robotics company in 2019, the judge found.

An Edwards spokesperson said the layoffs, affecting 3% of its workforce, are a “one-time right-sizing” deemed necessary after assessing resources amid the sale of the critical care business to BD.

Embecta’s first patch pump features a 300-unit insulin reservoir, based on feedback from people with Type 2 diabetes.

Since then, Beta Bionics has worked to integrate the device with CGMs. The company updated firmware to integrate the device with the Dexcom G7 CGM in December. Partnering with Abbott positions Beta ...

The agency sent warning letters to four companies and reminded the public it has not authorized any devices for cleaning or disinfecting CPAPs.

Siemens will pay 200 million euros for the manufacturing and distribution network of Novartis’ radiopharmaceutical molecular imaging business.

Physicians can use the test to identify people eligible for treatment with Bayer’s Vitrakvi and Eli Lilly’s Retevmo, which target cancers that have specific genetic features.

The European Society of Cardiology said the treatment may be considered for certain patients with uncontrolled, drug-resistant high blood pressure but outlined lingering concerns.

Changes include the addition of a larger valve size that company executives have said will open up 25% of the market in Europe.

The goal is to enable specialty care providers to perform genotyping while patients are undergoing routine clinical examination.